Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial

201184 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Breast Cancer Research and Treatment

Volume 126, Issue 2, pp. 463-470

Field-Weighted Citation Impact: 2.19